These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27575548)

  • 1. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
    Taylor HS; Kagan R; Altomare CJ; Cort S; Bushmakin AG; Abraham L
    Menopause; 2017 Jan; 24(1):27-34. PubMed ID: 27575548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing of FDA-approved and compounded hormone therapy differs by specialty.
    Constantine GD; Archer DF; Graham S; Bernick BA; Mirkin S
    Menopause; 2016 Oct; 23(10):1075-82. PubMed ID: 27648594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and attitudes of health professionals regarding menopausal hormone therapies.
    Yeganeh L; Boyle J; Teede H; Vincent A
    Climacteric; 2017 Aug; 20(4):348-355. PubMed ID: 28379046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.
    Lakey SL; Reed SD; LaCroix AZ; Grothaus L; Newton KM
    J Womens Health (Larchmt); 2010 Dec; 19(12):2175-81. PubMed ID: 21062201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing of hormone therapy in menopause and postmenopause.
    Hemminki E; Topo P
    J Psychosom Obstet Gynaecol; 1997 Jun; 18(2):145-57. PubMed ID: 9219111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources of information and HRT prescribing practices among gynecologists in Puebla, Mexico.
    Mueller KA; Sanchez GJ; Sievert LL
    Maturitas; 2003 Jun; 45(2):137-44. PubMed ID: 12787972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mind the gap: primary care physicians and gynecologists' knowledge about menopause and their attitudes to hormone therapy use in Jamaica.
    Harrison GM; Medley NN; Carroll KN; Simms-Stewart DA; Wynter SH; Fletcher HM; Rattray CA
    Menopause; 2021 Sep; 28(12):1385-1390. PubMed ID: 34469932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medical management of menopause: a four-country comparison care in urban areas.
    Sievert LL; Saliba M; Reher D; Sahel A; Hoyer D; Deeb M; Obermeyer CM
    Maturitas; 2008 Jan; 59(1):7-21. PubMed ID: 18178044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
    Hemminki E; Karttunen T; Hovi SL; Karro H
    Soc Sci Med; 2004 Jan; 58(1):89-97. PubMed ID: 14572923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Woman's Health Initiative and one of many unintended consequences.
    Simon JA
    Menopause; 2016 Oct; 23(10):1057-9. PubMed ID: 27623202
    [No Abstract]   [Full Text] [Related]  

  • 12. How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.
    Bush TM; Bonomi AE; Nekhlyudov L; Ludman EJ; Reed SD; Connelly MT; Grothaus LC; LaCroix AZ; Newton KM
    J Gen Intern Med; 2007 Sep; 22(9):1311-6. PubMed ID: 17634782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing Bioidentical Menopausal Hormone Therapy: A Survey of Physician Views and Practices.
    Dubaut JP; Dong F; Tjaden BL; Grainger DA; Duong J; Tatpati LL
    J Womens Health (Larchmt); 2018 Jul; 27(7):859-866. PubMed ID: 29583064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitude and knowledge for menopause management among health professionals in mainland China.
    Lin L; Feng P; Yu Q
    Climacteric; 2020 Dec; 23(6):614-621. PubMed ID: 32543223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?
    Vallejo MS; Witis S; Ojeda E; Mostajo D; Morera F; Meruvia N; Martino M; Lima S; Espinoza MT; Castillo O; Campostrini B; Danckers L; Blümel JE; Tserotas K; Sánchez H; Salinas C; Saavedra J; Rojas JA; Onatra W; Monterrosa A; Montaño A; Martínez J; González E; Gómez G; Calle A; Broutin G; Bencosme A; Arteaga E; Ayala F; Chedraui P
    Climacteric; 2016 Aug; 19(4):387-92. PubMed ID: 27327136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical.
    Power ML; Anderson BL; Schulkin J
    Menopause; 2009; 16(3):500-8. PubMed ID: 19169162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.
    Heinemann K; Rübig A; Strothmann A; Nahum GG; Heinemann LA
    J Womens Health (Larchmt); 2008 Sep; 17(7):1151-66. PubMed ID: 18774896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What factors account for hormone replacement therapy prescribing frequency?
    Newton KM; LaCroix AZ; Buist DS; Anderson LA; Delaney K
    Maturitas; 2001 Jul; 39(1):1-10. PubMed ID: 11451615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.
    Watson J; Wise L; Green J
    Eur J Clin Pharmacol; 2007 Sep; 63(9):843-9. PubMed ID: 17598097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
    Power ML; Schulkin J; Rossouw JE
    Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.